Skip to main content
Clinical Trials/NCT05261763
NCT05261763
Completed
Not Applicable

Study on the Effects of Trigger Point Dry Needling on Patients With Patello-femoral Pain Syndrome: A Randomized Controlled Trial

Riphah International University1 site in 1 country70 target enrollmentMarch 15, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patellofemoral Pain Syndrome
Sponsor
Riphah International University
Enrollment
70
Locations
1
Primary Endpoint
Goniometer
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

A double blinded clinical controlled trial will be performed on individuals with patello femoral pain syndrome in which Trigger Point Dry Needling will be given to experimental group while Sham Needling will be given to the control group, targeting the trigger points present in the Quadriceps of affected individuals assessing the pain,functional disability and range of motion of the affected individuals.

Detailed Description

A double blinded Randomized Controlled Trial of 6 months study after the approval of synopsis, will be conducted. Convenience sampling technique will be used to enroll the patients. Patients will be selected according to predefined inclusion and exclusion criteria. All patients who fulfill inclusion criteria will be allocated in two group through randomization by lottery method. Group A will receive TrP-DN and group B will receive Sham Needling. Both groups will be asked to perform stretching exercise of Quadriceps daily after needling. The patients' outcomes will be measured by VAS for pain intensity and Kujala Questionnaire for functional status. The comparison between pre-treatment and post-treatment data will be done after 3 months. Informed consents will be taken from each patient. Data entry and analysis will be done with SPSS 23.

Registry
clinicaltrials.gov
Start Date
March 15, 2021
End Date
March 1, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Both genders
  • Ages range from 18-40 years
  • They have clinical diagnosis of PFPS (the diagnosis was confirmed by a positive patellar grind test and tenderness of medial and lateral patellar facets)
  • Participants are also required to have a minimum pain score of 3 on Numeric Pain Scale
  • Kujala patellofemoral questionnaire score of 50 to 80 before the intervention.
  • Patients willing to participate

Exclusion Criteria

  • History of any following conditions
  • Participants who have received any treatment for PFPS within the 3 months
  • A history of lower extremities fracture or surgery
  • Presence of MSK diseases such as Acute Herniated Disc or Spondylolisthesis
  • History of any chronic disease e.g. Diabetes Mellitus

Outcomes

Primary Outcomes

Goniometer

Time Frame: 8th week

range of motion will be checked by Goniometer

Visual Analogue Scale

Time Frame: 8th week

Visual Analogue Scale

Kujala Questionnaire

Time Frame: 8th week

functional disability will be check by Kujala Questionnaire

Study Sites (1)

Loading locations...

Similar Trials